natgillin/translations-raw huggingface dataset:
Meda Pharma - Produtos Farmacêuticos, S.A. 
Portugalska Meda Pharma - Produtos Farmacêuticos, S.A.
Sandoz Farmacêutica, Lda. 
Portugalska Sandoz Farmacêutica, Lda.
Mylan, Lda. 
Portugalska Mylan, Lda.
Sanofi - Produtos Farmacêuticos, Lda. 
Portugalska Sanofi - Produtos Farmacêuticos, Lda.
Slovak Republic sanofi-aventis Slovakia s.r.o. 
Slovaška sanofi-aventis Slovakia s.r.o.
Zolpidem Genthion coated tablet oral use 
Zolpidem Genthion obložena tableta peroralna uporaba
Zolpidem Eurogenerics bruis 10 mg bruistabletten, bruistabletten effervescent tablet oral use 
Zolpidem Eurogenerics bruis 10 mg bruistabletten, bruistabletten šumeča tableta
Stilnoct 5mg fiilm-coated tablets coated tablet oral use 
Stilnoct 5mg fiilm-coated tablets obložena tableta peroralna uporaba
Zolpitop coated tablet oral use 
Zolpitop obložena tableta peroralna uporaba
Zolsana 5 mg coated tablets coated tablet oral use 
Zolsana 5 mg coated tablets obložena tableta peroralna uporaba
Stilnoct 10mg film-coated tablets coated tablet oral use 
Stilnoct 10mg film-coated tablets obložena tableta peroralna uporaba
Zolsana 10 mg coated tablets coated tablet oral use 
Zolsana 10 mg coated tablets obložena tableta peroralna uporaba
Generis Farmacêutica, S.A. Rua João de Deus, 19 2700-487 Amadora Portugal 
Portugalska Generis Farmacêutica, S.A. Rua João de Deus, 19
EDLUAR 10 mg nyelvalatti tabletta 10 mg sublingual tablet sublingual use 
EDLUAR 10 mg nyelvalatti tabletta 10 mg podjezična tableta sublingvalna uporaba
Stilnoct coated tablet oral use 
Stilnoct obložena tableta peroralna uporaba
Zolpeduar sublingual tablet sublingual use 
Zolpeduar podjezična tableta sublingvalna uporaba
Edluar 10 mg, tablet voor sublinguaal gebruik sublingual tablet sublingual use 
Edluar 10 mg, tablet voor sublinguaal gebruik podjezična tableta sublingvalna uporaba
coated tablet oral use 
obložena tableta peroralna uporaba
Edluar 5 mg, tablet voor sublinguaal gebruik sublingual tablet sublingual use 
Edluar 5 mg, tablet voor sublinguaal gebruik podjezična tableta sublingvalna uporaba
Dodorest coated tablet oral use 
Dodorest obložena tableta peroralna uporaba
Edluar 10 mg Sublingualtabletten 10 mg sublingual tablet sublingual use 
Edluar 10 mg Sublingualtabletten 10 mg podjezična tableta sublingvalna uporaba
Genthon GmbH Groesbeeker Weg, 1 D-47559 Kranenburg Germany 
Portugalska Genthon GmbH Groesbeeker Weg, 1
Edluar sublingual tablet sublingual use 
Edluar podjezična tableta sublingvalna uporaba
Edluar 10 mg Sublingualtabletten 10 mg sublingual tablet oral use 
Edluar 10 mg Sublingualtabletten 10 mg podjezična tableta peroralna uporaba
sublingual tablet sublingual use 
podjezična tableta sublingvalna uporaba
Edluar 10 mg podjezične tablete sublingual tablet sublingual use 
Edluar 10 mg sublingual tablets podjezična tableta sublingvalna uporaba
Edluar 5 mg podjezične tablete sublingual tablet sublingual use 
Edluar 5 mg sublingual tablets podjezična tableta sublingvalna uporaba
EDLUAR 5 mg nyelvalatti tabletta sublingual tablet sublingual use 
EDLUAR 5 mg nyelvalatti tabletta 5 mg podjezična tableta sublingvalna uporaba
Zolpeduar sublingual tablet oral use 
Zolpeduar podjezična tableta peroralna uporaba
Germany ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany 
Nemčija ratiopharm GmbH Graf Arco Strasse 3 D-89079 Ulm Germany
Edluar 5mg sublingual tablets sublingual tablet oral use 
Edluar 5mg sublingual tablets podjezična tableta peroralna uporaba
Edluar 5 mg sublingual tablets sublingual tablet oral use 
Edluar 5 mg sublingual tablets podjezična tableta peroralna uporaba
INSOM 10 mg pezsgőtabletta effervescent tablet oral use 
INSOM 10 mg pezsgőtabletta šumeča tableta
Edluar 10 mg sublingual tablets sublingual tablet oral use 
Edluar 10 mg sublingual tablets podjezična tableta peroralna uporaba
Edluar 10mg sublingual tablets sublingual tablet oral use 
Edluar 10mg sublingual tablets podjezična tableta peroralna uporaba
tablet oral use 
podjezična tableta peroralna uporaba
10 mg/ml oral drops, solution oral use 
10 mg/ml peroralne kapljice, raztopina
The European Commission issued a decision on 5 October 2010. 
Evropska komisija je odločbo izdala dne 5. oktobra 2010.
The company wanted the authorisation to be recognised in Bulgaria, Germany, France, Ireland and Italy (the ‘concerned Member States'). 
Družba je želela, da bi bilo dovoljenje za promet z zdravilom priznano v Bolgariji, Nemčiji, Franciji, na Irskem in v Italiji (v „zadevnih državah članicah“).
Kristina Dunder (Sweden) 
Kristina Dunder (Švedska)
Daniela Melchiorri (Italy) 
Daniela Melchiorri (Italija)
It is used to reduce the risk of fractures (in the hip and spine. 
Uporablja se za zmanjšanje tveganja zlomov (kolkov in hrbtenice).
However, the Member States were not able to reach an agreement and the Swedish medicines regulatory agency referred the matter to the CHMP for arbitration on 29 April 2010. 
Vendar države članice niso mogle doseči soglasja, zato je švedski regulatorni organ za zdravila dne 29. aprila 2010 zadevo napotil na CHMP v arbitražo.
Co-rapporteur: 
Soporočevalka:
Blocking the action of these cells leads to less bone loss. 
Zaviranje delovanja teh celic vodi do manjše izgube kostne mase.
Why was Norsed Combi D reviewed? 
Zakaj je bilo zdravilo Norsed Combi D pregledano?
The grounds for the referral were concerns over the evidence provided of the efficacy of this combination medicine, the validity of claims that this way of combining active substances would bring a benefit to patients compared with the individual active substances, and the validity of claims that the medicine improved compliance (the ability of patients to stick to their treatment). 
Razlogi za napotitev so bili zadržki glede dokazov o učinkovitosti tega kombiniranega zdravila, veljavnosti trditev, da ta način kombiniranja zdravilnih učinkovin bolnikom koristi bolj kot posamezne zdravilne učinkovine, ter veljavnosti trditev, da zdravilo izboljšuje vztrajanje bolnikov pri zdravljenju.
20 May 2010 
20. maj 2010
It stops the action of the osteoclasts, the cells that are involved in breaking down the bone tissue. 
Ta zaustavlja delovanje osteoklastov, celic, ki sodelujejo pri razgradnji kostnega tkiva.
What is Norsed Combi D? 
Kaj je zdravilo Norsed Combi D?
Based on evaluation of the currently available data and the scientific discussion within the Committee, the CHMP concluded that the benefits of Norsed Combi D outweigh its risks, and therefore the marketing authorisation for Norsed Combi D should be granted in all concerned Member States. 
Na podlagi ocene trenutno razpoložljivih podatkov in znanstvene razprave znotraj odbora je CHMP zaključil, da koristi zdravila Norsed Combi D odtehtajo njegova tveganja, zato je treba odobriti dovoljenje za promet z zdravilom Norsed Combi D v vseh zadevnih državah članicah.
The European Medicines Agency has completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Norsed Combi D. The Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of Norsed Combi D outweigh its risks, and that the marketing authorisation granted in Sweden can be recognised in other Member States of the EU. 
Evropska agencija za zdravila je končala postopek arbitraže, do katerega je prišlo po nesoglasju med državami članicami Evropske unije (EU) glede odobritve zdravila Norsed Combi D. Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji EMEA je zaključil, da koristi zdravila Norsed Combi D odtehtajo njegova tveganja in da se lahko dovoljenje za promet z zdravilom, ki je bilo odobreno na Švedskem, prizna tudi v drugih državah članicah EU.
Norsed Combi D is used for the treatment of osteoporosis (a disease that makes bones fragile) in women who have been through the menopause. 
Zdravilo Norsed Combi D se uporablja za zdravljenje osteoporoze (bolezni, ki povzroča krhkost kosti) pri ženskah po menopavzi.
It consists of tablets containing 35 mg risedronate sodium, together with sachets of effervescent granules containing 1000 mg calcium as calcium carbonate and 880 IU colecalciferol. 
Sestavljeno je iz tablet, ki vsebujejo 35 mg natrijevega risedronata, skupaj z vrečicami šumečih zrnc, ki vsebujejo 1000 mg kalcija v obliki kalcijevega karbonata in 880 i.e. kolekalciferola.
The active substances in the effervescent granules provide calcium and vitamin D, which are needed for normal bone formation. 
Zdravilne učinkovine šumečih zrnc vsebujejo kalcij in vitamin D, ki sta nujna za normalno tvorbo kosti.
The active substance in the tablets, risedronate sodium, is a bisphosphonate. 
Zdravilna učinkovina tablet, natrijev risedronat, je bisfosfonat.
Norsed Combi D is a medicine that contains three active substances, risedronate sodium, calcium carbonate and colecalciferol. 
Norsed Combi D je zdravilo, ki vsebuje tri zdravilne učinkovine - natrijev risedronat, kalcijev karbonat in kolekalciferol.
Sanofi-aventis S.p.A. submitted Norsed Combi D for mutual recognition on the basis of the initial authorisation granted by Sweden on 3 October 2006. 
je predložila zdravilo Norsed Combi D v postopek medsebojnega priznavanja na podlagi začetnega dovoljenja za promet, ki je bilo odobreno na Švedskem dne 3. oktobra 2006.
MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size 
Farmacevtska oblika Pot uporabe
None known. 
Niso znani.
The clinical relevance of this reduced susceptibility is not fully explored. 
Klinični pomen te zmanjšane občutljivosti še ni popolnoma raziskan.
Efficacy studies under field conditions have not been conducted. 
Študije učinkovitosti v pogojih na terenu niso bile izvedene.
Where feed intake is reduced, use the following formula: 
Kjer pride do zmanjšanega prehranjevanja, uporabite naslednjo formulo:
Treatment of PPE (ileitis) 
Zdravljenje PPE (ileitis)
Do not release pheasants for at least two days after the end of medication. 
Ne izpustite fazanov še vsaj dva dni po koncu zdravljenja.
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu). 
Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) http://www.ema.europa.eu
Laboratory studies in animals have not produced any evidence of a teratogenic effect. 
Z laboratorijskimi študijami na živalih niso bili dokazani teratogeni učinki.
Tylvalosin has a sixteen membered ring. 
Tilvalozin ima šestnajst členski obroč.
If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon. 
Če opazite kakršne koli stranske učinke, tudi tiste, ki niso navedeni v teh navodilih za uporabo ali menite, da zdravilo ni delovalo, obvestite svojega veterinarja.
OTHER CONDITIONS: 
• DRUGI POGOJI:
4.8 Interaction with other medicinal products and other forms of interaction 
4.8 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Niso znane.
10 days 
10 dni
Consideration must be given to pigs whose daily feed intake is reduced or restricted. 
Upoštevati morate prašiče, katerih dnevni vnos krme je zmanjšan ali omejen.
Keep the container tightly closed. 
Vsebnik shranjujte tesno zaprt.
In order to obtain the correct dose, the concentration of Aivlosin has to be adjusted accordingly. 
Da bi lahko zagotovili pravilno odmerjanje, je potrebno koncentracijo zdravila Aivlosin ustrezno prilagoditi.
One additional yearly periodic safety update report (PSUR) is required, and thereafter PSURs shall be submitted at three-yearly intervals, unless otherwise required. 
Potrebno je eno dodatno letno redno posodobljeno poročilo o varnosti zdravila (PSUR), potem pa se redna posodobljena poročila o varnosti zdravila (PSUR) predložijo v triletnih presledkih, razen če je navedeno drugače.
The tmax for tylvalosin is about 2.2 hours; the terminal half-life for the elimination is approximately 2.2 hours. 
Tmax tilvalozina je okrog 2,2 uri; končni razpolovni čas odstranjevanja iz telesa je približno 2,2 uri.
Wash contaminated skin. 
Kontaminirano kožo umijte.
No breakpoint for Brachyspira hyodysenteriae has been established. 
Za Brachyspira hyodysenteriae ni bilo določene prelomne točke.
Their effect is essentially confined to rapidly dividing organisms. 
Njihov učinek je v glavnem omejen na mikroorganizme, ki se hitro delijo.
They bind to the donor site and prevent the translocation necessary for keeping the peptide chain growing. 
Vežejo se na donatorsko mesto in preprečijo translokacijo, ki je potrebna za nadaljnjo rast peptidne verige.
Ecuphar Italia S.R.L. 
Italia Ecuphar Italia S.R.L.
Larger groups should be treated with medicated feeding stuff containing the premix. 
Večje skupine je treba zdraviti z medicinirano krmo, ki vsebuje predmešanico.
Do not use within 14 days of the start of the laying period. 
Ne uporabite v obdobju 14 dni pred začetkom obdobja nesnosti.
The intake of medicated water depends on the clinical condition of the animals. 
Količina zaužite zdravilne vode je odvisna od kliničnega stanja živali.
These studies demonstrated a modest but statistically significant reduction in the incidence of lower respiratory lesions (lung and air sac) and clinical signs in turkeys treated with tylvalosin compared with negative controls. 
Te študije so pokazale zmerno, vendar statistično pomembno zmanjšanje pojavnosti lezij spodnjih dihalnih poti (pljuč in zračnih mehurčkov) in kliničnih znakov pri puranih, zdravljenih s tilvalozinom, v primerjavi z negativnimi kontrolami.
Do not use within 21 days of the start of the laying period. 
Ne uporabite v obdobju 21 dni pred začetkom obdobja nesnosti.
Date of last renewal: 9 September 2014 
Datum podaljšanja dovoljenja za promet: 9. september 2014
Calculate the total amount of product required with the formula: 
Celotno količino izdelka, ki je potrebna, izračunajte po naslednji formuli:
They are generally considered bacteriostatic. 
Na splošno veljajo za bakteriostatične.
Treat all the birds in the affected flock. 
Zdravite vse ptice v prizadeti jati.
No signs of intolerance have been observed in growing pigs at up to 10 times the recommended dose. 
Pri rastočih prašičih niso opazili nobenih znakov neprenašanja tudi pri odmerkih, ki so bili 10-krat večji od priporočenih.
In field studies investigating the effect of treatment and metaphylaxis on mycoplasmosis, all birds (approximately 3 weeks old) received the product when clinical signs were evident in 2 - 5% of the flock. 
V terenskih študijah, v katerih so preučevali učinek zdravljenja in metafilakse na mikoplazmozo, so vse ptice (stare približno 3 tedne) prejele zdravilo, ko je 2-5 % jate kazalo klinične znake bolezni.
This is achieved by thoroughly mixing Aivlosin into approximately 200-500 g of feed and then thoroughly mixing this pre-mixture into the remainder of the daily ration. 
To dosežemo tako, da dobro zmešamo zdravilo Aivlosin s približno 200-500 g krme in nato temeljito vmešamo to predmešanico v preostali dnevni obrok.
Pelleting conditions involve a single pre-conditioning step with steam for 5 minutes and pelleting at not more than 70 °C under normal conditions. 
Peletiranje obsega 5-minutno predpripravo v enem koraku s paro in peletiranje pri največ 70 °C pod normalnimi pogoji.
Mixing instructions: 
Navodila za mešanje:
Belphar LDA Sintra Business Park No 7, 
Sintra Business Park No 7,
Medication should only be used for short-term amelioration of clinical signs in breeder flocks whilst awaiting confirmation of diagnosis of Mycoplasma gallisepticum infection. 
Zdravilo se sme uporabljati le za kratkoročno izboljšanje kliničnih znakov pri plemenskih pitovnih jatah, medtem ko se čaka na potrditev diagnoze okužbe z Mycoplasma gallisepticum.
Select the correct number of sachets according to the amount of product required. 
Izberite pravilno število vrečk glede na potrebno količino izdelka.
It acts by inhibiting protein synthesis in the bacteria cell. 
Deluje tako, da inhibira sintezo proteina v bakterijskih celicah.
Eggs (chicken): zero days. 
Jajca (kokoši): nič dni.
Hydrated magnesium silicate, wheat flour. 
Hidratirani magnezijev silikat, pšenična moka
The veterinary medicinal product may be mixed directly into the drinking water system or first mixed as a stock solution into a smaller amount of water, which is then added into the drinking water system. 
Zdravilo lahko vmešate neposredno v sistem vode za pitje ali pa ga najprej vmešate kot koncentrirano raztopino v manjšo količino vode, ki jo nato dodate v sistem vode za pitje.
(as tylvalosin tartrate) For the full list of excipients see section 6.1. 
(v obliki tilvalozinijevega tartrata) Za celoten seznam pomožnih snovi glejte poglavje 6.1.
1 kg/tonne* 
1 kg/tono*
2 kg/tonne* 
2 kg/tono*
Resistance to tylvalosin by Mycoplasma hyopneumoniae and Lawsonia intracellularis has not been reported or found in the field to date. 
O rezistenci mikroorganizmov Mycoplasma hyopneumoniae in Lawsonia intracellularis doslej na terenu niso poročali oziroma je niso ugotovili.
The feed containing the oral powder should be provided as the sole ration for the periods recommended above. 
Krma s peroralnim praškom mora biti edini obrok, ki je živalim na voljo v zgoraj priporočenih obdobjih.
For use in individual pigs on farms where only a small number of pigs are to receive the treatment. 
Za zdravljenje posameznih prašičev na farmah, kjer je zdravilo namenjeno le manjšemu številu prašičev.
The veterinary medicinal product should only be added to dry non-pelleted feed. 
Zdravilo za uporabo v veterinarski medicini smete dodati samo suhi nepeletirani krmi.
Efficacy of tylvalosin against O. rhinotracheale in turkeys was demonstrated in a challenge model using co-infection with avian metapneumovirus and a single strain of O. rhinotracheale under strictly controlled conditions. 
Učinkovitost tilvalozina proti O. rhinotracheale pri puranih je bila dokazana v modelu z umetno okužbo z uporabo navzkrižne kontaminacije s ptičjim metapneumovirusom in enim sevom O. rhinotracheale pod strogo nadzorovanimi pogoji.
Total weight of product in grams = total bodyweight of pigs to be treated in kg x 5 / 625. 
Celotna teža zdravila v gramih = skupna telesna masa prašičev, ki jih boste zdravili, v kg x 5 / 625.
Skin and fat Liver Tylvalosin Poultry 200 µg/kg Eggs The excipients listed in section 6.1 of the SPC either are allowed substances for which Table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required, or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this product. 
Pomožne snovi, navedene v poglavju 6.1 Povzetka glavnih značilnosti zdravila (SPC), so bodisi dovoljene snovi, za katere preglednica 1 priloge Uredbe Komisije (EU) št. 37/2010 navaja, da MRL-ji niso potrebni, bodisi velja, da niso vključene v Uredbo (ES) št. 470/2009, kadar se uporabljajo v tem zdravilu.
ATCvet code: QJ01FA92. 
Oznaka ATC vet : QJ01FA92.
Plessis Beucher 35220 Châteaubourg Tél : +33 (0)2 99 00 92 92 Fax : +33 (0)2 99 00 97 23 
35220 Châteaubourg Tél : +33 (0)2 99 00 92 92 Fax : +33 (0)2 99 00 97 23
At the recommended dose, lung lesions and weight loss are reduced but infection with Mycoplasma hyopneumoniae is not eliminated. 
Ob dajanju priporočenega odmerka se zmanjšajo pljučne lezije in izguba telesne mase, vendar pa okužbe z Mycoplasma hyopneumoniae ne moremo eliminirati.
Not for use in birds producing or intended to produce eggs for human consumption. 
Ni za uporabo pri pticah, ki proizvajajo ali so namenjene proizvodnji jajc za prehrano ljudi.
Infection with Mycoplasma gallisepticum is reduced but not eliminated at the recommended dose. 
Okužba z Mycoplasma gallisepticum se zmanjša, vendar se pri priporočenem odmerku ne odpravi.
Cross-resistance within the macrolide group of antibiotics cannot be excluded. 
Navzkrižne odpornosti znotraj makrolidne skupine antibiotikov ni mogoče izključiti.
Opened bags should not be stored. 
Ne shranjujte odprtih vreč.
Medicated drinking water should be replaced every 24 hours. 
Vodo za pitje s primešanim zdravilom morate zamenjati vsakih 24 ur.
Only a sufficient amount of medicated drinking water should be prepared to cover the daily requirements. 
Pripravite le toliko vode za pitje z raztopljenim zdravilom, da bo zadostila dnevnim potrebam.
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. 
Uporaba zdravila naj temelji na testiranju občutljivosti bakterije, izolirane iz živali.
The strategy for Mycoplasma gallisepticum infection should include efforts to eliminate the pathogen from the parent generation. 
Strategija za zdravljenje okužbe z Mycoplasma gallisepticum mora vključevati prizadevanja za odpravo patogena pri starševski jati.
The active metabolite 3-AT has a mean concentration of 57.9 ng/g and 441 ng/g, respectively. 
Povprečni koncentraciji aktivnega presnovka 3-AT sta 57,9 ng/g oziroma 441 ng/g.
They have different sized lactone rings and due to the dimethylamino group, are basic. 
Imajo različno velike laktonske obroče, zaradi dimetilamino skupine pa so bazične spojine.
Bodyweight range (kg) 
Razpon telesne mase (kg)
Carrier: 
Nosilec:
It is sound clinical practice to base treatment on susceptibility testing of the bacteria isolated from the animal. 
Dobra klinična praksa je, da zdravljenje temelji na testiranju občutljivosti bakterij, izoliranih iz živali.
Macrolides (including tylvalosin) have been shown to have effects on the innate immune system, which may augment the direct effects of the antibiotic on the pathogen and aid the clinical situation. 
Makrolidi (vključno s tilvalozinom) imajo dokazane učinke na naravni imunski sistem, ki lahko ojačajo neposredne učinke antibiotika na bolezenske organizme in tako pomagajo pri klinični situaciji.
Feed to which the oral powder has been added should be replaced if not consumed within 24 hours. 
Krmo z dodanim peroralnim praškom morate zamenjati, če je prašiči ne pojedo v 24 urah.
Available in pack sizes containing 5 kg or 20 kg of product. 
Na voljo v pakiranju po 5 kg ali 20 kg zdravila.
When used as an aid in reducing the development of clinical signs and mortality (where infection in ovum with Mycoplasma gallisepticum is likely): 
Kadar se uporablja kot pomoč pri zmanjševanju razvoja kliničnih znakov in smrtnosti (kjer je verjetna infekcija in ovo z Mycoplasma gallisepticum):
Medicated feed may then be pelleted. 
Medicinirano krmo nato lahko peletiramo.
Mixing instructions 
Navodila za mešanje
There is evidence that the concentration of macrolides is higher at the site of infection than in plasma, in particular in neutrophils, alveolar macrophages and alveolar epithelial cells. 
Obstajajo dokazi, da je koncentracija makrolidov na mestu infekcije višja kot v plazmi, zlasti v neutrofilcih, alveolarnih makrofagih in alveolarnih epitelijskih celicah.
Bacteria can develop resistance to antimicrobial substances. 
Bakterije lahko razvijejo rezistenco na antimikrobna sredstva.
NO ENTRY Antiinfectious agents / 
Ni vpisov Zdravila za zdravljenje infekcij /
In further field studies, chicks from parent stock with evidence of Mycoplasma gallisepticum infection were administered Aivlosin for the first three days of life followed by a second course at 16 - 19 days of age (a period of management stress). 
V nadaljnjih terenskih študijah so piščanci iz starševske jate, pri kateri so ugotovili okužbo z Mycoplasma gallisepticum, prejemali zdravilo Aivlosin prve tri dni življenja, čemur je sledil drugi cikel pri starosti 16-19 dni (obdobje upravljanja stresa).
Macrolides are generally considered bacteriostatic and mycoplasmastatic. 
Makrolidi na splošno veljajo za bakteriostatične in mikoplazmastatične.
In older pigs, or in pigs with reduced appetite, or on restricted feed intake, inclusion levels may need to be increased to achieve target dose. 
Pri starejših prašičih ali prašičih z zmanjšanim apetitom oziroma z omejenim prehranjevalnim režimom bo za doseganje tarčnega odmerka morda potrebno zvišati razmerje vsebnosti.